Since 1999 cannabis has been legal in one form or another in Canada. In the intervening years, legislation governing the supply, distribution and variety of cannabis products has expanded under Health Canada’s guidance and supervision. In 2016, limited production for personal medical use was legalized. In 2018, the recreational use of cannabis is anticipated.
Canada, at the forefront of medicinal marijuana, has developed much of the infrastructure to support and supply the anticipated marketplace, recreational as well as medicinal. Recreational marijuana legalization is expected to create a $22 billion industry in Canada. The medicinal market is forecast at in excess of $1 billion.
Medview Connect has identified favorable fundamental market regulatory and demographic trends with respect to cannabis and established distribution partnerships with the leading LP’s in the industry (Aphria, Canopy, The Hydropothecary)
Through the Medview Connect platform, on-demand access to License Producers (LP’s) of cannabis products and medical staff simplify the registration process in a convenient and compliant format.